results

An ongoing Phase I/II clinical trial is evaluating VX-880 as a treatment for type 1 diabetes (T1D). Image courtesy of Ahmet Misirligul/Shutterstock. Vertex Pharmaceuticals The company announced positive data from …

WASHINGTON (March 25, 2024)—Diabetes affects more than 1 in 10 Americans, or more than 38 million people. People with diabetes who maintain their blood sugar levels in a near normal …

Diabetes affects more than 1 in 10 people. or more than 38 million -; Americans. People with diabetes who maintain their blood sugar levels in a near normal range generally …

The technology uses CGM data to predict blood sugar levels one hour in advance and makes corrections every five minutes based on individual blood sugar goals. Image credit: Insulet. US …

Study design We performed a study to assess the feasibility of a teleintervention on mental health parameters of patients with type 1 diabetes during an outbreak. Previous databases were used …

Updated February 26, 2024: This article has been updated with new findings from the groundbreaking DiRECT study published in The Lancet. A three-year extension of our groundbreaking DIRECT study reveals …

Guariguata, L. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice 103, 137–149 (2014). Article  PubMed  CAS  Google Scholar  DALYs, G. …

In the ever-expanding market of health supplements, GlucoBerry claims to offer a revolutionary solution to the global health epidemic of diabetes and associated conditions by addressing a hidden trigger of …

Type 2 diabetes is a common condition in which sugar (glucose) levels in the blood become too high. People with the disease are often overweight or inactive, or have a …